VUS Genetics

3X Genetics

This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.

Valius

This company develops molecular diagnostic platforms to identify therapeutic options for patients with rare and advanced cancers.

Nostos Genomics

The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.

Codebreaker

This company develops a synthetic biology platform generating causal genomics data to help clinicians and researchers interpret genetic variants for disease diagnosis.

Genomic Prediction

The company develops genetic screening tests for IVF embryos to assess disease risks for fertility clinics and prospective parents.

Probably Genetic

This company provides genetic testing and diagnostic tools to help patients with undiagnosed rare diseases access clinical trials and treatments.

Scenic Biotech

This company develops disease-modifying small molecule therapeutics for patients with rare genetic and neurodegenerative disorders using its proprietary genetic modifier discovery platform.

Healthcare insights platform

This company provides a data analytics platform that integrates genetic information and clinical research to assist pharmaceutical firms in developing precision medicine and treatments.